טוען...
Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis
BACKGROUND: Cystic fibrosis (CF) lung disease is characterized by structural changes in the airways and parenchyma. No sputum biomarker exists to measure the degree of active structural destruction during pulmonary exacerbation in patients with CF. The noninvasive measurement of desmosine, a breakdo...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American College of Chest Physicians
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789924/ https://ncbi.nlm.nih.gov/pubmed/19567495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0217 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|